|
| ORIGINAL ARTICLE |
 |
|
|
| Year : 2019 |
Volume
: 12 | Issue : 4 | Page
: 299-302 |
|
There is no association between premature ovarian insufficiency and levels of fetuin-A/α2-Heremans-Schmid glycoprotein
A Seval Ozgu-Erdinc, Zeynep Asli Oskovi Kaplan, Yaprak Engin-Ustun, Nafiye Yilmaz, Gulcin Yildirim, Aytekin Tokmak, Kudret Erkenekli, Salim Erkaya, Dilek Uygur
Ankara Dr. Zekai Tahir Burak Health Practice Research Center, University of Health Sciences, Ankara, Turkey
Correspondence Address:
Dr. A Seval Ozgu-Erdinc
Ankara Dr. Zekai Tahir Burak Health Practice Research Center, University of Health Sciences, Ankara
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jhrs.JHRS_104_19
|
|
|
Objective: Fetuin-A is a well-known negative acute-phase protein and has been used liberally to predict vascular disease. The aim of this study was to evaluate the association between serum human fetuin-A/alpha2-Heremans–Schmid glycoprotein levels and idiopathic premature ovarian insufficiency (POI). Methods: A total of 75 women were included in this case–control study between January 2013 and December 2013. Serum fetuin-A concentrations were measured in 36 women with idiopathic POI and 39 healthy women with regular cycles. Blood samples were drawn after a 12-h overnight fast and were kept at −80°C for subsequent assay. The serum levels of fetuin-A were assessed by commercial ELISA kits (BioVendor Laboratory Medicine Inc., Brno, Czech Republic) and serum concentration values were expressed as μg/ml. Results: The mean serum fetuin-A levels of idiopathic POI and control women were 229.02 ± 27.79 and 232.37 ± 65.56, respectively, with P = 0.771 (independent samples t-test). Our results showed no statistically significant difference between serum fetuin-A levels of idiopathic POI women and controls. Conclusion: The mean values of serum fetuin-A in idiopathic POI women were not significantly different from controls, which implies that there is no significant association between serum fetuin-A levels and idiopathic POI.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
|
|
